ALSINA-FERNANDEZ Jorge,BOKVIST Bengt Krister,COSKUN Tamer,CUMMINS Robert Chadwick
申请号：
SI201630358
公开号：
SI3242887T1
申请日:
2016.01.05
申请国别(地区):
SI
年份:
2019
代理人:
摘要：
The present invention relates to dual incretin peptide mimetic compounds that agonize receptors for both human glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), and may be useful for treating type 2 diabetes mellitus (T2D).
